Complications of hepatitis B virus infection continue to increase in New Zealand [Image: Adobe Stock]
This article reviews the current hepatitis B situation in New Zealand, including appropriate treatment
References
1. Sarin SK, Kumar M, Lau GK, et al. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatol Int 2016;10(1):1–98.
2. Gane EJ, Charlton MR, Mohamed R, et al. Asian consensus recommendations on optimizing the diagnosis and initiation of treatment of hepatitis B virus infection in resource-limited settings. J Viral Hepat 2020;27(5):466–75.
3. El-Serag HB, Davila JA. Surveillance for hepatocellular carcinoma: in whom and how? Therap Adv Gastroenterol 2011;4(1):5–10.
4. Kao WY, Chao Y, Chang CC, et al. Prognosis of early-stage hepatocellular carcinoma: The clinical implications of substages of Barcelona Clinic Liver Cancer system based on a cohort of 1265 Patients. Medicine (Baltimore) 2015;94(43):e1929.
5. Huang CFS, Yu ML. The clinical utility of Elecsys GAAD score in the diagnosis of hepatocellular carcinoma. Asian Pacific Association for the Study of the Liver Single Topic Conference on Hepatocellular Carcinoma 2022.
